Home › Funds › PFM Health Sciences, LP › AXSM

PFM Health Sciences, LP position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

PFM Health Sciences, LP reported holding 219,596 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$53.8M, representing 4.71% of its reported portfolio and ranking #2 among its reported holdings. PFM Health Sciences, LP has disclosed AXSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)219.60K sh
Reported value held$53.75M
Portfolio Weight4.71%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's AXSM position evolved

PFM Health Sciences, LP first disclosed a stake in AXSM in Q3 2023 at 523,210 shares (US$36.6M). The position peaked in Q1 2025 at 556,545 shares, worth US$64.9M. Across 12 filings, PFM Health Sciences, LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 219,596 shares valued at US$53.8M — a reduction of -44,708 shares quarter over quarter.. Notable position changes include a 53% trim in Q4 2025 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 523.21K $36.57M New
Q4 2023 467.43K $37.20M Reduce
Q1 2024 467.43K $37.30M Hold
Q2 2024 467.43K $37.63M Hold
Q3 2024 467.43K $42.01M Hold
Q4 2024 467.43K $39.55M Hold
Q1 2025 556.54K $64.91M Add
Q2 2025 483.11K $50.43M Reduce
Q3 2025 530.33K $64.41M Add
Q4 2025 251.56K $45.95M Reduce
Q1 2026 264.30K $44.67M Add
Q2 2026 219.60K $53.75M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 53 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has PFM Health Sciences, LP held AXSM?

PFM Health Sciences, LP has disclosed AXSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in AXSM?

As of Q2 2026, PFM Health Sciences, LP holds 219.60K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $53.75M, representing 4.71% of its reported portfolio and ranking #2.

Has PFM Health Sciences, LP been buying or selling AXSM?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in AXSM. The position peaked in Q1 2025 at 556.54K shares.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.